EMED — Electromedical Technologies Cashflow Statement
0.000.00%
Last trade - 00:00- $0.17m
- $2.44m
- $1.35m
Annual cashflow statement for Electromedical Technologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.74 | -3.87 | -8.48 | -3.47 | -2.64 |
| Depreciation | |||||
| Non-Cash Items | 0.822 | 2.85 | 7.03 | 2.17 | 0.652 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.617 | -0.335 | 0.232 | 0.506 | 0.567 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -0.281 | -1.34 | -1.19 | -0.773 | -1.42 |
| Capital Expenditures | — | — | — | — | -0.15 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | — | 1.89 |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | — | — | — | — | 1.74 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.281 | 1.6 | 1.31 | 0.759 | -0.608 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0 | 0.265 | 0.118 | -0.015 | -0.281 |